Page last updated: 2024-08-23

perfosfamide and Carcinoma, Lewis Lung

perfosfamide has been researched along with Carcinoma, Lewis Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beckett, MA; Gupta, VK; Koons, A; Kufe, DW; Lee, JY; Manan, A; Mauceri, HJ; Montag, AG; Park, JO; Schumm, LP; Seetharam, S; Weichselbaum, RR1
Dupuis, NP; Emi, Y; Goff, DA; Robinson, MF; Teicher, BA1

Other Studies

2 other study(ies) available for perfosfamide and Carcinoma, Lewis Lung

ArticleYear
Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
    Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:5

    Topics: Angiogenesis Inhibitors; Angiostatins; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Movement; Cells, Cultured; Cyclophosphamide; Drug Screening Assays, Antitumor; Drug Synergism; Endothelium, Vascular; Humans; Linear Models; Lung Neoplasms; Mice; Mice, Inbred C57BL; Morphogenesis; Neoplasm Metastasis; Neovascularization, Physiologic; Peptide Fragments; Plasminogen; Protein Synthesis Inhibitors; Single-Blind Method; Tumor Cells, Cultured

2002
Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma.
    Oncology research, 1995, Volume: 7, Issue:5

    Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Carmustine; Cell Hypoxia; Cell Survival; Cisplatin; Cyclohexanes; Cyclophosphamide; DNA, Neoplasm; Drug Combinations; Male; Melphalan; Mice; Mice, Inbred C57BL; Minocycline; O-(Chloroacetylcarbamoyl)fumagillol; Platinum; Sesquiterpenes; Tumor Cells, Cultured

1995